drugset / Trial / NCT00162149
ATV/Ritonavir Nevirapine Interaction (USPAC)
Non-randomizedParallel-groupOpen-label
Summary
Open-Label, multiple-dose, drug interaction study to assess the effect of nevirapine on the pharmacokinetics of atazanavir in HIV-infected individuals.
Timeline
- Start
- 2005-10
- Primary completion
- 2006-07
- Completion
- 2006-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atazanavir | Other / unclassified | 300 mg | Oral |
| Subject | Atazanavir | Other / unclassified | 400 mg | Oral |
| Comparator | Nevirapine | Small molecule | 200 mg | Oral |
| Background | Ritonavir | Other / unclassified | 100 mg | Oral |